Experimental group:Fuzhengquxie prescription

4 trials

Sponsors

Department of Oncology of Shanghai Traditional Chinese Medicine Hospital

Conditions

Stage IA-IB adenocarcinoma of the lungStage IB-IIB lung adenocarcinoma

Unknown Phase

Therapy with FZQXF to prevent the relapse of postoperative patients with stage IB-IIB lung adenocarcinoma after surgery and adjuvant chemotherapy:a prospective, cohort, two-center clinical study

Active, not recruitingITMCTR2000003597

Department of Oncology of Shanghai Traditional Chinese Medicine HospitalStage IB-IIB lung adenocarcinoma

Start: 2020-10-01Updated: 2023-02-20

Therapy with FZQXF to prevent the relapse of postoperative patients with early lung adenocarcinoma patients: a randomized, double-blind, placebo-parallel controlled, multicenter clinical trial

Active, not recruitingITMCTR2000003600

Department of Oncology of Shanghai Traditional Chinese Medicine HospitalStage IA-IB adenocarcinoma of the lung

Start: 2020-10-01Updated: 2023-02-20

Therapy with FZQXF to prevent the relapse of postoperative patients with stage IB-IIB lung adenocarcinoma after surgery and adjuvant chemotherapy:a prospective, cohort, two-center clinical study

Active, not recruitingChiCTR2000036042

Department of Oncology of Shanghai Traditional Chinese Medicine HospitalStage IB-IIB lung adenocarcinoma

Start: 2020-10-01Updated: 2020-08-31

Therapy with FZQXF to prevent the relapse of postoperative patients with early lung adenocarcinoma patients: a randomized, double-blind, placebo-parallel controlled, multicenter clinical trial

Active, not recruitingChiCTR2000036045

Department of Oncology of Shanghai Traditional Chinese Medicine HospitalStage IA-IB adenocarcinoma of the lung

Start: 2020-10-01Updated: 2020-08-31